Abstract

Convection-enhanced delivery (CED) is a drug delivery technique used to deliver therapeutics directly to the brain and is a continually evolving technique to treat glioblastoma. Early versions of CED have proven to result in inadequate drug volume dispersed (Vd), increasing the likelihood of tumor recurrence. Fiber optic microneedle devices (FMDs) with the ability to deliver fluid and thermal energy simultaneously have shown an ability to increase Vd, but FMDs have historically had low light transmission efficiency. In this study, we present a new fabrication method, solid fiber inside capillary (SFIC) FMD, and a modified fusion splicing (FS) method with the goal of increasing light delivery efficiency. The modified FS FMD resulted in an increase in light transmission efficiency between 49% and 173% compared to previous prototypes. However, the FS FMD resulted in significantly lower transmission efficiencies compared to the SFIC FMD (p ≤ 0.04) and FS FMDs perform much worse when light-absorptive materials, like black dye, are placed in the bore. The light absorption of a candidate cytotoxic agent, QUAD-CTX, appear to be similar to water, and light delivery through FS FMDs filled with QUAD-CTX achieves a transmission efficiency of 85.6 ± 5.4%. The fabrication process of the SFIC FMDs results in extremely fragile FMDs. Therefore, the use of a modified FS FMD fabrication process appears to be better suited for balancing the desire to increase light transmission efficiency while retaining a sturdy FMD construction.

References

1.
Ostrom
,
Q. T.
,
Patil
,
N.
,
Cioffi
,
G.
,
Waite
,
K.
,
Kruchko
,
C.
, and
Barnholtz-Sloan
,
J. S.
,
2020
, “
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017
,”
Neuro-oncology
,
22
(
Suppl_1
), pp.
iv1
iv96
.10.1093/neuonc/noaa200
2.
Wallner
,
K. E.
,
Galicich
,
J. H.
,
Krol
,
G.
,
Arbit
,
E.
, and
Malkin
,
M. G.
,
1989
, “
Patterns of Failure Following Treatment of Glioblastoma Mulitform and Anaplastic Astrocytoma
,”
Int. J. Radiat. Oncol. Biol. Phys.
,
16
(
6
), pp.
1405
1409
.10.1016/0360-3016(89)90941-3
3.
Hochberg
,
F. H.
, and
Pruitt
,
A.
,
1980
, “
Assumptions in the Radiotherapy of Glioblastoma
,”
Neurology
,
30
(
9
), pp.
907
907
.10.1212/WNL.30.9.907
4.
Pardridge
,
W. M.
,
2005
, “
The Blood-Brain Barrier: Bottleneck in Brain Drug Development
,”
J. Am. Soc. Exp. Neurotherapeutics
,
2
(
1
), pp.
3
14
.10.1602/neurorx.2.1.3
5.
Bobo
,
R. H.
,
Laske
,
D. W.
,
Akbasak
,
A.
,
Morrison
,
P. F.
,
Dedrick
,
R. L.
, and
Oldfield
,
E. H.
,
1994
, “
Convection-Enhanced Delivery of Macromolecules in the Brain
,”
Proc. Natl. Acad. Sci. USA
,
91
(
6
), pp.
2076
2080
.10.1073/pnas.91.6.2076
6.
Degen
,
J. W.
,
Walbridge
,
S.
,
Vortmeyer
,
A. O.
,
Oldfield
,
E. H.
, and
Lonser
,
R. R.
,
2003
, “
Safety and Efficacy of Convection-Enhanced Delivery of Gemcitabine or Carboplatin in a Malignant Glioma Model in Rats
,”
J. Neurosurg.
,
99
(
5
), pp.
893
898
.10.3171/jns.2003.99.5.0893
7.
Kaiser
,
M. G.
,
Parsa
,
A. T.
,
Fine
,
R. L.
,
Hall
,
J. S.
,
Chakrabarti
,
I.
, and
Bruce
,
J.
,
2000
, “
Tissue Distribution and Antitumor Activity of Topotecan Delivered by Intracerebral Clysis in a Rat Glioma Model
,”
Neurosurgery
,
47
(
6
), pp.
1391
1399
.10.1097/00006123-200012000-00026
8.
Laske
,
D. W.
,
Youle
,
R. J.
, and
Oldfield
,
E. H.
,
1997
, “
Tumor Regression With Regional Distribution of the Targeted Toxin TF-CRM107 in Patients With Malignant Brain Tumors
,”
Nat. Med.
,
3
(
12
), pp.
1362
1368
.10.1038/nm1297-1362
9.
Rand
,
R. W.
,
Kreitman
,
R. J.
,
Patronas
,
N.
,
Varricchio
,
F.
,
Pastan
,
I.
, and
Puri
,
R. K.
,
2000
, “
Intratumoral Administration of Recombinant Circularly. Permuted Interleukin-4-Pseudonomas Exotoxin in Patients With High-Grade Glioma
,”
Clin Cancer Res.
,
6
(
6
), pp.
2157
2165
.https://pubmed.ncbi.nlm.nih.gov/10873064/
10.
Weber
,
F. W.
,
Floeth
,
F.
,
Asher
,
A.
,
Bucholz
,
R.
,
Berger
,
M. S.
,
Prados
,
M.
,
Chang
,
S.
, and
Bruce
,
J.
,
2003
, “
Local Convection Enhanced Delivery of IL4-Pseudonomas Exotoxin (NBI-3001) for Treatment of Patients With Recurrent Malignant Glioma
,”
Acta Neurochir
,
88
, pp.
93
103
.10.1007/978-3-7091-6090-9_15
11.
Lidar
,
Z.
,
Mardor
,
Y.
,
Jonas
,
T.
,
Pfeffer
,
R.
,
Faibel
,
M.
,
Nass
,
D.
,
Hadani
,
M.
, and
Ram
,
Z.
,
2004
, “
Convection-Enhanced Delivery of Paclitaxel for the Treatment of Recurrent Malignant Glioma: A Phase I/II Clinical Study
,”
J. Neurosurg.
,
100
(
3
), pp.
472
479
.10.3171/jns.2004.100.3.0472
12.
Marks
,
W. J.
,
Ostrem
,
J. L.
,
Verhagen
,
L.
,
Starr
,
P. A.
,
Larson
,
P. S.
,
Bakay
,
R. A.
,
Taylor
,
R.
,
Cahn-Weiner
,
D. A.
,
Stoessl
,
A. J.
,
Olanow
,
C. W.
, and
Bartus
,
R. T.
,
2008
, “
Safety and Tolerability of Intraputaminal Delivery of CERE-120 (Adeno-Associated Virus Serotype 2–Neurturin) to Patients With Idiopathic Parkinson's Disease: An Open-Label, Phase I Trial
,”
Lancet Neurol.
,
7
(
5
), pp.
400
408
.10.1016/S1474-4422(08)70065-6
13.
Lang
,
A. E.
,
Gill
,
S.
,
Patel
,
N. K.
,
Lozano
,
A.
,
Nutt
,
J. G.
,
Penn
,
R.
,
Brooks
,
D. J.
, et al.,
2006
, “
Randomized Controlled Trial of Intraputamenal Glial Cell Line–Derived Neurotrophic Factor Infusion in Parkinson Disease
,”
Ann. Neurol.
,
59
(
3
), pp.
459
466
.10.1002/ana.20737
14.
Kunwar
,
S.
,
Chang
,
S.
,
Westphal
,
M.
,
Vogelbaum
,
M.
,
Sampson
,
J.
,
Barnett
,
G.
,
Shaffrey
,
M.
, et al.,
2010
, “
Phase III Randomized Trial of CED of IL13-PE38QQR versus Gliadel Wafers for Recurrent Glioblastoma
,”
Neuro-oncology
,
12
(
8
), pp.
871
881
.10.1093/neuonc/nop054
15.
Salvatore
,
M. F.
,
Ai
,
Y.
,
Fischer
,
B.
,
Zhang
,
A. M.
,
Grondin
,
R. C.
,
Zhang
,
Z.
,
Gerhardt
,
G. A.
, and
Gash
,
D. M.
,
2006
, “
Point Source Concentration of GDNF May Explain Failure of Phase II Clinical Trial
,”
Exp. Neurol.
,
202
(
2
), pp.
497
505
.10.1016/j.expneurol.2006.07.015
16.
Sampson
,
J. H.
,
Archer
,
G.
,
Pedain
,
C.
,
Wembacher-Schröder
,
E.
,
Westphal
,
M.
,
Kunwar
,
S.
,
Vogelbaum
,
M. A.
, et al.,
2010
, “
Poor Drug Distribution as a Possible Explanation for the Results of the PRECISE Trial
,”
J. Neurosurg.
,
113
(
2
), pp.
301
309
.10.3171/2009.11.JNS091052
17.
Ellor
,
S. V.
,
Pagano-Young
,
T. A.
, and
Avgeropoulos
,
N. G.
,
2014
,
Glioblastoma: Background, Standard Treatment Paradigms, and Supportive Care Considerations
,
SAGE Publications Sage CA
,
Los Angeles, CA
.
18.
Krauze
,
M. T.
,
Saito
,
R.
,
Noble
,
C.
,
Tamas
,
M.
,
Bringas
,
J.
,
Park
,
J. W.
,
Berger
,
M. S.
, and
Bankiewicz
,
K.
,
2005
, “
Reflux-Free Cannula for Convection-Enhanced High-Speed Delivery of Therapeutic Agents
,”
J. Neurosurg.
,
103
(
5
), pp.
923
929
.10.3171/jns.2005.103.5.0923
19.
Vazquez
,
L. C.
,
Hagel
,
E.
,
Willenberg
,
B. J.
,
Dai
,
W.
,
Casanova
,
F.
,
Batich
,
C. D.
, and
Sarntinoranont
,
M.
,
2012
, “
Polymer-Coated Cannulas for the Reduction of Backflow During Intraparenchymal Infusions
,”
J. Mater. Sci. Mater. Med.
,
23
(
8
), pp.
2037
2046
.10.1007/s10856-012-4652-0
20.
Yin
,
D.
,
Forsayeth
,
J.
, and
Bankiewicz
,
K. S.
,
2010
, “
Optimized Cannula Design and Placement for Convection-Enhanced Delivery in Rat Striatum
,”
J. Neurosci. Methods
,
187
(
1
), pp.
46
51
.10.1016/j.jneumeth.2009.12.008
21.
Gill
,
T.
,
Barua
,
N. U.
,
Woolley
,
M.
,
Bienemann
,
A. S.
,
Johnson
,
D. E.
,
Sullivan
,
S. O.
,
Murray
,
G.
,
Fennelly
,
C.
,
Lewis
,
O.
,
Irving
,
C.
,
Wyatt
,
M. J.
,
Moore
,
P.
, and
Gill
,
S. S.
,
2013
, “
In Vitro and In Vivo Testing of a Novel Recessed-Step Catheter for Reflux-Free Convection-Enhanced Drug Delivery to the Brain
,”
J. Neurosci. Methods
,
219
(
1
), pp.
1
9
.10.1016/j.jneumeth.2013.06.008
22.
Elenes
,
E. Y.
, and
Rylander
,
C. G.
,
2017
, “
Maximizing Local Access to Therapeutic Deliveries in Glioblastoma. Part II: Arborizing Catheter for Convection-Enhanced Delivery in Tissue Phantoms
,” Glioblastoma,
S.
De Vleeschouwer
, ed.,
Exon Publication
,
Brisbane, QLD
, pp.
359
372
.
23.
Vogelbaum
,
M. A.
,
Brewer
,
C.
,
Barnett
,
G. H.
,
Mohammadi
,
A. M.
,
Peereboom
,
D. M.
,
Ahluwalia
,
M. S.
, and
Gao
,
S.
,
2018
, “
First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1
,”
J. Neurosurg.
, pp.
1
10
.10.3171/2017.10.JNS171845
24.
Sudhakar
,
V.
,
Naidoo
,
J.
,
Samaranch
,
L.
,
Bringas
,
J. R.
,
Lonser
,
R. R.
,
Fiandaca
,
M. S.
, and
Bankiewicz
,
K. S.
,
2020
, “
Infuse-as-You-Go Convective Delivery to Enhance Coverage of Elongated Brain Targets
,”
J. Neurosurg.
,
133
(
2
), pp.
530
537
.10.3171/2019.4.JNS19826
25.
Lewis
,
O.
,
Woolley
,
M.
,
Johnson
,
D. E.
,
Fletcher
,
J.
,
Fenech
,
J.
,
Pietrzyk
,
M. W.
,
Barua
,
N. U.
,
Bienemann
,
A. S.
,
Singleton
,
W.
,
Evans
,
S. L.
, and
Gill
,
S. S.
,
2018
, “
Maximising Coverage of Brain Structures Using Controlled Reflux, Convection-Enhanced Delivery and the Recessed Step Catheter
,”
J. Neurosci. Methods
,
308
, pp.
337
345
.10.1016/j.jneumeth.2018.08.029
26.
Mehta
,
J. N.
,
McRoberts
,
G. R.
, and
Rylander
,
C. G.
,
2020
, “
Controlled Catheter Movement Affects Dye Dispersal Volume in Agarose Gel Brain Phantoms
,”
Pharmaceutics
,
12
(
8
), p.
753
.10.3390/pharmaceutics12080753
27.
Akhter
,
F.
,
Manrique-Bedoya
,
S.
,
Moreau
,
C.
,
Smith
,
A. L.
,
Feng
,
Y.
,
Mayer
,
K. M.
, and
Hood
,
R. L.
,
2021
, “
Assessment and Modeling of Plasmonic Photothermal Therapy Delivered Via a Fiberoptic Microneedle Device Ex Vivo
,”
Pharmaceutics
,
13
(
12
), p.
2133
.10.3390/pharmaceutics13122133
28.
Hood
,
R. L.
,
Rossmeisl
,
J. H.
, Jr.
,
Andriani
,
R. T.
, Jr.
,
Wilkinson
,
A. R.
,
Robertson
,
J. L.
, and
Rylander
,
C. G.
,
2013
, “
Intracranial Hyperthermia Through Local Photothermal Heating With a Fiberoptic Microneedle Device
,”
Lasers Surg. Med.
,
45
(
3
), pp.
167
174
.10.1002/lsm.22117
29.
Hood
,
R. L.
,
Andriani
,
R. T.
, Jr.
,
Emch
,
S.
,
Robertson
,
J. L.
,
Rylander
,
C. G.
, and
Rossmeisl
, and
J. H.
, Jr.
,
2013
, “
Fiberoptic Microneedle Device Facilitates Volumetric Infusate Dispersion During Convection-Enhanced Delivery in the Brain
,”
Lasers Surg. Med.
,
45
(
7
), pp.
418
426
.10.1002/lsm.22156
30.
Hood
,
R. L.
,
Ecker
,
T.
,
Andriani
,
R.
,
Robertson
,
J.
,
Rossmeisl
,
J.
, and
Rylander
,
C. G.
, “
Augmenting Convection-Enhanced Delivery Through Simultaneous co-Delivery of Fluids and Laser Energy With a Fiberoptic Microneedle Device
,”
Proc. SPIE
,
8576
, pp.
85760G
85760G
.10.1117/12.2004854
31.
Hood
,
R. L.
,
Andriani
,
R. T.
,
Ecker
,
T. E.
,
Robertson
,
J. L.
, and
Rylander
,
C. G.
,
2015
, “
Characterizing Thermal Augmentation of Convection-Enhanced Drug Delivery With the Fiberoptic Microneedle Device
,”
Engineering
,
1
(
3
), pp.
344
350
.10.15302/J-ENG-2015077
32.
Elenes
,
E. Y.
,
Mehta
,
J. N.
,
Hsu
,
F.-C.
,
Whitlow
,
C. T.
,
Debinski
,
W.
,
Rossmeisl
,
J.
,
Tatter
,
S.
, and
Rylander
,
C. G.
,
2021
, “
Convection-Enhanced Arborizing Catheter System Improves Local/Regional Delivery of Infusates Versus a Single-Port Catheter in Ex Vivo Porcine Brain Tissue
,”
ASME J. Eng. Sci. Medical Diagnostics Ther.
,
4
(
1
), p. 011003.10.1115/1.4048935
33.
Hood
,
R. L.
,
2013
, “
Development of a Fiberoptic Microneedle Device for Simultaneous Co-Delivery of Fluid Agents and Laser Light With Specific Applications in the Treatment of Brain and Bladder Cancers
,”
Doctor of Philosophy, Virginia Polytechnic Institute and State University
,
Blacksburg, VA
.
34.
Mehta
,
J. N.
, and
Rylander
,
C. G.
,
2020
, “
Solid Fiber Inside Capillary and Modified Fusion-Spliced Fiber Optic Microneedle Devices
,”
ASME
Paper No. DMD2020-9050.10.1115/DMD2020-9050
35.
Akhter
,
F.
,
Bascos
,
G. N. W.
,
Canelas
,
M.
,
Griffin
,
B.
, and
Hood
,
R. L.
,
2020
, “
Mechanical Characterization of a Fiberoptic Microneedle Device for Controlled Delivery of Fluids and Photothermal Excitation
,”
J. Mech. Behav. Biomed. Mater.
,
112
, p.
104042
.10.1016/j.jmbbm.2020.104042
36.
Vandergrift
,
W. A.
,
Patel
,
S. J.
,
Nicholas
,
J. S.
, and
Varma
,
A. K.
,
2006
, “
Convection-Enhanced Delivery of Immunotoxins and Radioisotopes for Treatment of Malignant Gliomas
,”
Neurosurg. Focus
,
20
(
4
), p.
E13
.10.3171/foc.2006.20.4.8
37.
Hayes
,
J.
,
2009
,
The FOA Reference Guide to Fiber Optics and Study Guide to FOA Certification
,
Fiber Optic Association
, Santa Monica, CA.
38.
Thorlabs,
2000
, “
FN96A - Guide to Connectorization and Polishing of Optical Fibers
,” Thorlabs, Newton, NJ.
39.
NKT Photonics
2009
, “
Splicing Single Mode PCFs
,”
NKT Photonics Application Note, NKT Photonics
,
Birkerod, Denmark
, p.
3
.
40.
Kato
,
Y.
,
Seikai
,
S.
, and
Tateda
,
M.
,
1982
, “
Arc-Fusion Splicing of Single-Mode Fibers. 1: Optimum Splice Conditions
,”
Appl. Opt.
,
21
(
7
), pp.
1332
1336
.10.1364/AO.21.001332
41.
Furukawa Electric Co., Ltd.,
S178 Fusion Splicer User's Manual
,
Furukawa Electric Co., Ltd
., Tokyo, Japan.
42.
Svaasand
,
L. O.
, and
Ellingsen
,
R.
,
1983
, “
Optical Properties of Human Brain
,”
Photochem. Photobiol.
,
38
(
3
), pp.
293
299
.10.1111/j.1751-1097.1983.tb02674.x
43.
Svaasand
,
L. O.
, and
Eixingsen
,
R.
,
1985
, “
Optical Penetration in Human Intracranial Tumors
,”
Photochem. Photobiol.
,
41
(
1
), pp.
73
76
.10.1111/j.1751-1097.1985.tb03450.x
44.
Wykosky
,
J.
,
Gibo
,
D. M.
, and
Debinski
,
W.
,
2007
, “
A Novel, Potent, and Specific ephrinA1-Based Cytotoxin Against EphA2 Receptor–Expressing Tumor Cells
,”
Mol. Cancer Ther.
,
6
(
12
), pp.
3208
3218
.10.1158/1535-7163.MCT-07-0200
45.
Debinski
,
W.
,
Dickinson
,
P.
,
Rossmeisl
,
J. H.
,
Robertson
,
J.
, and
Gibo
,
D. M.
,
2013
, “
New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
,”
PLoS One
,
8
(
10
), p.
e77719
.10.1371/journal.pone.0077719
46.
Rossmeisl
,
J. H.
,
Herpai
,
D.
,
Quigley
,
M.
,
Cecere
,
T. E.
,
Robertson
,
J. L.
,
D'Agostino
,
R. B.
,
Hinckley
,
J.
,
Tatter
,
S. B.
,
Dickinson
,
P. J.
, and
Debinski
,
W.
,
2020
, “
Phase I Trial of Convection-Enhanced Delivery of IL13RA2 and EPHA2 Receptor Targeted Cytotoxins in Dogs With Spontaneous Intracranial Gliomas
,”
Neuro-oncology
,
22
(
Suppl_2
), p.
ii94
.10.1093/neuonc/noaa215.388
47.
Vargas
,
G.
,
Chan
,
E. K.
,
Barton
,
J. K.
,
Rylander
, III
,
H. G.
, and
Welch
,
A. J.
,
1999
, “
Use of an Agent to Reduce Scattering in Skin
,”
Lasers Surg. Med.
,
24
(
2
), pp.
133
141
.10.1002/(SICI)1096-9101(1999)24:2<133::AID-LSM9>3.0.CO;2-X
48.
Kanner
,
A.
,
2007
, “
Convection-Enhanced Delivery High-Grade Gliomas
,”
High Grade Gliomas
, pp.
303
314
.10.1007/978-1-59745-185-7
49.
Fernández
,
L. J.
,
Altuna
,
A.
,
Tijero
,
M.
,
Gabriel
,
G.
,
Villa
,
R.
,
Rodríguez
,
M. J.
,
Batlle
,
M.
,
Vilares
,
R.
,
Berganzo
,
J.
, and
Blanco
,
F.
,
2009
, “
Study of Functional Viability of SU-8-Based Microneedles for Neural Applications
,”
J. Micromech. Microeng.
,
19
(
2
), p.
025007
.10.1088/0960-1317/19/2/025007
You do not currently have access to this content.